|
Pharmaceutical Preparations
|
D004364 |
[Drugs intended for human or veterinary use, presented in their finished dosage form. Included here are materials used in the preparation and/or formulation of the finished dosage form.
] |
|
Pharmaceutical Preparations, Dental
|
D053210 |
[Drugs intended for DENTISTRY.
] |
|
Pharmaceutical Research
|
D000071220 |
[RESEARCH activity focused on pharmaceutical products and services.
] |
|
Pharmaceutical Services
|
D010593 |
[Total pharmaceutical services provided by qualified PHARMACISTS. In addition to the preparation and distribution of medical products, they may include consultative services provided to agencies and institutions which do not have a qualified pharmacist.
, A pharmacy service model advocated by the pharmacy profession and approved by legislatures in many states and countries. This model expands the role of PHARMACISTS with additional training (CLINICAL PHARMACISTS) in a patient-centered evidence-based medication management program based on collaboration with physicians and patients.
] |
|
Pharmaceutical Services, Online
|
D060946 |
[Pharmacy services accessed via electronic means.
] |
|
Pharmaceutical Solutions
|
D019999 |
[Homogeneous liquid preparations that contain one or more chemical substances dissolved, i.e., molecularly dispersed, in a suitable solvent or mixture of mutually miscible solvents. For reasons of their ingredients, method of preparation, or use, they do not fall into another group of products.
] |
|
Pharmaceutical Vehicles
|
D014677 |
[A carrier or inert medium used as a solvent (or diluent) in which the medicinally active agent is formulated and or administered. (Dictionary of Pharmacy, 1986)
] |
|
Pharmacies
|
D010594 |
[Facilities for the preparation and dispensing of drugs.
] |
|
Pharmacists
|
D010595 |
[Those persons legally qualified by education and training to engage in the practice of pharmacy.
, Pharmacists with clinical training to provide patient-centered evidence-based PHARMACEUTICAL CARE. Clinical pharmacists assist with the design, implementation, monitoring, and modification of the patient's drug treatment.
] |
|
Pharmacoepidemiology
|
D017891 |
[The science concerned with the benefit and risk of drugs used in populations and the analysis of the outcomes of drug therapies. Pharmacoepidemiologic data come from both clinical trials and epidemiological studies with emphasis on methods for the detection and evaluation of drug-related adverse effects, assessment of risk vs benefit ratios in drug therapy, patterns of drug utilization, the cost-effectiveness of specific drugs, methodology of postmarketing surveillance, and the relation between pharmacoepidemiology and the formulation and interpretation of regulatory guidelines. (Pharmacoepidemiol Drug Saf 1992;1(1); J Pharmacoepidemiol 1990;1(1))
] |
|
Pharmacogenetics
|
D010597 |
[A branch of genetics which deals with the genetic variability in individual responses to drugs and drug metabolism (BIOTRANSFORMATION).
, A subdiscipline of PHARMACOGENETICS using GENOMICS and PROTEOMICS methodology to study genetic variability of responses to drugs and drug metabolism (BIOTRANSFORMATION).
] |
|
Pharmacogenomic Testing
|
D000071185 |
[The detection of genetic variability (e.g., PHARMACOGENOMIC VARIANTS) relevant to PHARMACOGENETICS and PRECISION MEDICINE. The purpose of such genetic testing is to help determine the most effective treatment options and their optimum dosages with least potential risks for DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS.
] |
|
Pharmacogenomic Variants
|
D000071184 |
[Naturally occurring genetic variations associated with drug response (e.g., dosage, extent and rate of metabolic processes). While these variants are not markers for GENETIC PREDISPOSITION TO DISEASE they influence PHARMACOKINETICS and pharmacodynamics and often occur on genes encoding drug metabolism enzymes and transporters (e.g., ANGIOTENSIN CONVERTING ENZYME; CYTOCHROME P-450 CYP2D6).
] |
|
Pharmacognosy
|
D010598 |
[The science of drugs prepared from natural-sources including preparations from PLANTS, animals, and other organisms as well as MINERALS and other substances included in MATERIA MEDICA. The therapeutic usage of plants is PHYTOTHERAPY.
] |
|
Pharmacokinetics
|
D010599 |
[Dynamic and kinetic mechanisms of exogenous chemical DRUG LIBERATION; ABSORPTION; BIOLOGICAL TRANSPORT; TISSUE DISTRIBUTION; BIOTRANSFORMATION; elimination; and DRUG TOXICITY as a function of dosage, and rate of METABOLISM. LADMER, ADME and ADMET are abbreviations for liberation, absorption, distribution, metabolism, elimination, and toxicology.
] |
|
Pharmacologic Actions
|
D020228 |
[A broad category of chemical actions and uses that result in the prevention, treatment, cure or diagnosis of disease. Included here are drugs and chemicals that act by altering normal body functions, such as the REPRODUCTIVE CONTROL AGENTS and ANESTHETICS. Effects of chemicals on the environment are also included.
] |
|
Pharmacological Phenomena
|
D000069437 |
[Interactions that occur between a living organism and chemicals that affect normal or abnormal biochemical function.
, The metabolism of drugs and their mechanisms of action.
] |
|
Pharmacological and Toxicological Phenomena
|
D002620 |
[Synthesis, metabolism, and poisoning associated with drugs, pharmaceuticals, and other active molecules. Toxicological phenomena also include the adverse effects of physical phenomena such as RADIATION and NOISE.
] |
|
Pharmacology
|
D010600 |
[The study of the origin, nature, properties, and actions of drugs and their effects on living organisms.
] |
|
Pharmacology, Clinical
|
D010601 |
[The branch of pharmacology that deals directly with the effectiveness and safety of drugs in humans.
] |
